The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease
Completed Not Applicable NCT02256306
Study Description
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease
Study Details
- Registry ID:
- NCT02256306
- Conditions:
- Mild-To-Moderate Alzheimer's Disease, Alzheimer's Disease
- Phase:
- Not Applicable
- Target Enrollment:
- 18 participants
- Start Date:
- Age Range:
- 50–90 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Stanford University
Stanford, California, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.